National Health Investors, Inc. (NHI)
NYSE: NHI · IEX Real-Time Price · USD
68.36
+0.83 (1.23%)
Jul 2, 2024, 4:00 PM EDT - Market closed
National Health Investors Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for NHI stock have an average target of 62.33, with a low estimate of 52 and a high estimate of 69. The average target predicts a decrease of -8.82% from the current stock price of 68.36.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for NHI stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 2 | 3 | 3 | 4 | 4 |
| Hold | 5 | 4 | 4 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Maintains $58 → $65 | Hold | Maintains | $58 → $65 | -4.92% | Jun 26, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $63 → $69 | Buy | Maintains | $63 → $69 | +0.94% | May 30, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $55 → $58 | Hold | Maintains | $55 → $58 | -15.16% | Apr 4, 2024 |
| Wedbush | Wedbush | Buy Maintains $64 → $66 | Buy | Maintains | $64 → $66 | -3.45% | Mar 18, 2024 |
| BMO Capital | BMO Capital | Hold → Buy Upgrades $67 | Hold → Buy | Upgrades | $67 | -1.99% | Mar 12, 2024 |
Financial Forecast
Revenue This Year
341.42M
from 319.84M
Increased by 6.75%
Revenue Next Year
394.16M
from 341.42M
Increased by 15.45%
EPS This Year
2.94
from 3.13
Decreased by -6.10%
EPS Next Year
3.03
from 2.94
Increased by 3.09%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 369.9M | 467.3M | 547.3M | 629.3M | 716.7M |
| Avg | 341.4M | 394.2M | 526.4M | 462.3M | 689.4M |
| Low | 317.3M | 328.8M | 510.8M | 309.8M | 668.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.7% | 36.9% | 38.8% | 19.5% | 55.0% |
| Avg | 6.7% | 15.4% | 33.6% | -12.2% | 49.1% |
| Low | -0.8% | -3.7% | 29.6% | -41.2% | 44.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 3.12 | 3.18 | 3.23 |
| Avg | 2.94 | 3.03 | 3.11 |
| Low | 2.79 | 2.91 | 3.02 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.4% | 8.2% | 6.7% |
| Avg | -6.1% | 3.1% | 2.7% |
| Low | -10.8% | -1.0% | -0.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.